Solid tumor Clinical Trials in Los Angeles, CA

As of September 2026, 81 paid clinical trials are recruiting for Solid tumor in Los Angeles, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Related specialties in Los Angeles

Oncology· 811

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

81 clinical trials for Solid tumor

·Clear filters·

Email me when a new solid tumor trial opens in Los Angeles, CA.

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles, Duarte +6 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Study of FID-022 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles, Duarte +1 more location

Sponsor: Fulgent Pharma LLC.

Sex: All·Age: 18+

Code: NCT06694480·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for Solid Tumor

Drug: PT0253

Sites in Los Angeles +6 more locations

Sponsor: PAQ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06797336·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06233942·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +1 more location

Sponsor: CStone Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06741644·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for Solid Tumors

Sites in Los Angeles +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT05471856·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

for Solid Tumor, Adult

1 location in Los Angeles

Sponsor: BioInvent International AB

Sex: All·Age: 18+

Code: NCT04219254·Phase 1, Phase 2·Recruiting·Listed Jan 2020

Apply to this trial

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

for Advanced Malignant Solid Neoplasm

Sites in Los Angeles +2 more locations

Sponsor: RasCal Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT04678648·Phase 1·Recruiting·Listed Dec 2020

Apply to this trial

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06625593·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

for Hematologic Malignancy

Drug: Pelabresib

Sites in Los Angeles +5 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06401356·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in Los Angeles +8 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT07123103·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study of VET3-TGI in Patients With Solid Tumors

for Solid Tumor, Adult

Sites in Los Angeles, Orange +5 more locations

Sponsor: KaliVir Immunotherapeutics

Sex: All·Age: 18+

Code: NCT06444815·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles, Irvine +5 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06697197·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

SNV4818 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +4 more locations

Sponsor: Pikavation Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06736704·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +6 more locations

Sponsor: LigaChem Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05941507·Phase 1, Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

for Advanced Solid Tumor

Sites in Los Angeles, Fullerton +7 more locations

Sponsor: TORL Biotherapeutics, LLC

Sex: All·Age: 18+

Code: NCT05103683·Phase 1·Recruiting·Listed Nov 2021

Apply to this trial

A Study of LM-24C5 For Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +5 more locations

Sponsor: LaNova Medicines Limited

Sex: All·Age: 18+

Code: NCT06187402·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles, Santa Monica +3 more locations

Sponsor: ABL Bio, Inc.

Sex: All·Age: 18+

Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021

Apply to this trial

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

for Solid Tumors

Sites in Los Angeles +3 more locations

Sponsor: Apollomics Inc.

Sex: All·Age: 18+

Code: NCT03175224·Phase 2·Recruiting·Listed Jun 2017

Apply to this trial

Trial of DFP-14927 in Advanced Solid Tumors

for Solid Tumor

Sites in Los Angeles +1 more location

Sponsor: Delta-Fly Pharma, Inc.

Sex: All·Age: 18+

Code: NCT03943004·Phase 1·Recruiting·Listed May 2019

Apply to this trial

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

for Advanced Malignant Solid Neoplasm

Sites in Los Angeles, Santa Monica +427 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: All ages

Code: NCT05564377·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

Sites in Los Angeles, Santa Barbara +144 more locations

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016

Apply to this trial

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for Malignant Female Reproductive System Neoplasm

Sites in Los Angeles, Encinitas +179 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06126276·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

Sites in Los Angeles, Duarte +189 more locations

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in Los Angeles, Downey +225 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for Non-small Cell Lung Cancer

Sites in Los Angeles, San Francisco +19 more locations

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

for Metastatic Malignant Solid Neoplasm

Sites in Los Angeles, Duarte +16 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05687110·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

for Hematopoietic and Lymphatic System Neoplasm

Sites in Los Angeles & Bishop

Sponsor: University of Southern California

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT07332312·Recruiting·Listed Jan 2026

Apply to this trial

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for Anatomic Stage III Breast Cancer AJCC v8

Sites in Los Angeles, Newport Beach +5 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 12+

Code: NCT05372640·Phase 1·Recruiting·Listed May 2022

Apply to this trial

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

for Hematopoietic and Lymphatic System Neoplasm

1 location in Los Angeles

Sponsor: University of Southern California

Sex: All·Age: 18+

Code: NCT07306338·Recruiting·Listed Dec 2025

Apply to this trial

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for Hematopoietic and Lymphatic System Neoplasm

Sites in Los Angeles, Downey +74 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 15 - 20

Code: NCT06410209·Phase 2·Recruiting·Listed May 2024

Apply to this trial

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for Wilms Tumor

Drug: Selinexor

Sites in Los Angeles, Palo Alto +14 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 12 Months+

Code: NCT05985161·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

for Metastatic Malignant Solid Neoplasm

Sites in Los Angeles, Duarte & Stanford

Sponsor: Anusha Kalbasi

Sex: All·Age: 18 - 75

Code: NCT04119024·Phase 1·Recruiting·Listed Oct 2019

Apply to this trial

Access to Genetic Testing in Underserved Patients With Cancer

for Breast Carcinoma

Sites in Los Angeles +1 more location

Sponsor: University of Southern California

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06422455·Recruiting·Listed May 2024

Apply to this trial

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

Sites in Los Angeles +5 more locations

Sponsor: InduPro, Inc.

Sex: All·Age: 18+

Code: NCT07602842·Phase 1, Phase 2·Recruiting·Listed May 2026

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in Los Angeles, Duarte +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +3 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 18+

Code: NCT06880549·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for Solid Tumor

Drug: INBRX-106

Sites in Los Angeles, Glendale +11 more locations

Sponsor: Inhibrx Biosciences, Inc

Sex: All·Age: 18+

Code: NCT04198766·Phase 1, Phase 2·Recruiting·Listed Dec 2019

Apply to this trial

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for Solid Tumor, Adult

Sites in Los Angeles, San Diego +13 more locations

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT04913285·Phase 1·Recruiting·Listed Jun 2021

Apply to this trial